US Codex
Bill
Notes

Stopping Transgender Operation Payments and Wacky Expenses for Illegal Residents and Detainees Act of 2024

H.R. 9586 · 118th Congress · Sep 12, 2024 · Lineage

A BILL

To prohibit Federal funds from being used to provide certain gender transition procedures to individuals in the custody of the Department of Homeland Security and the Department of Health and Human Services.

Section 1 Short title

This Act may be cited as the “Stopping Transgender Operation Payments and Wacky Expenses for Illegal Residents and Detainees Act of 2024” or the “STOP WEIRD Act of 2024”.

Sec. 2 Prohibiting federal funds from being used to provide certain gender transition procedures

(a)
In general— Notwithstanding any other provision of law, no Federal funds may be used or otherwise made available to provide or refer for a specified gender transition procedure to an individual in the custody of the Department of Homeland Security or the Department of Health and Human Services or to reimburse any entity for providing such a procedure to such an individual.
(b)
Specified gender transition procedure defined—
(1)
In general— For purposes of this paragraph, except as provided in paragraph (2), the term specified gender transition procedure means, with respect to an individual, any of the following when performed for the purpose of intentionally changing the body of such individual to no longer correspond to their sex:
(A)
Performing any surgery, including—
(i)
castration;
(ii)
orchiectomy;
(iii)
scrotoplasty;
(iv)
vasectomy;
(v)
hysterectomy;
(vi)
oophorectomy;
(vii)
ovariectomy;
(viii)
metoidioplasty;
(ix)
penectomy;
(x)
phalloplasty;
(xi)
vaginoplasty;
(xii)
vaginectomy;
(xiii)
vulvoplasty;
(xiv)
reduction thyrochondroplasty;
(xv)
chondrolaryngoplasty;
(xvi)
mastectomy; and
(xvii)
any plastic, cosmetic, or aesthetic surgery that feminizes or masculinizes the facial or other body features of an individual.
(B)
Any placement of chest implants to create feminine breasts.
(C)
Any placement of fat or artificial implants in the gluteal region.
(D)
Administering, supplying, prescribing, dispensing, distributing, or otherwise conveying to an individual medications, including—
(i)
gonadotropin-releasing hormone (GnRH) analogues or other puberty-blocking drugs to stop or delay normal puberty; and
(ii)
testosterone, estrogen, or other androgens to an individual at doses that are supraphysiologic than would normally be produced endogenously in a healthy individual of the same age and sex.
(2)
Sex— For purposes of paragraph (1), the term sex means the indication of male or female sex by reproductive potential or capacity, sex chromosomes, naturally occurring sex hormones, gonads, or internal or external genitalia present at birth.